Company profile: Intelesens
1.1 - Company Overview
Company description
- Provider of intelligent, wearable, non-invasive, wireless vital signs monitoring devices for hospital and home patient monitoring, leveraging proprietary high-sensitivity arrhythmia and respiratory algorithms, and offering defibrillation and ECG electrodes plus custom electrode design, prototyping, and end-to-end manufacturing compliant with international regulatory standards.
Products and services
- Electrode Manufacturing: Produces defibrillation and ECG electrodes via international regulatory-compliant end-to-end manufacturing, ensuring compliance with international regulatory standards for finished electrode assemblies
- Defibrillator Electrodes: Biocompatible electrodes engineered for defibrillation, customizable shapes, up to 5-year shelf life, suitable for hospitals, EMS, and public deployments
- ECG Electrodes: Adhesion-optimized electrodes for ECG monitoring, architected for secure skin contact, minimal irritation, and excellent signal detection, with 1.5–3 year shelf life
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Intelesens
Ablacon
HQ: United States
Website
- Description: Provider of AI-guided atrial fibrillation therapies, including the Ablamap System to localize and characterize functional mechanisms of AF for customized ablation; the Ablacath Mapping Catheter, used with Ablamap to identify and ablate sources outside the pulmonary veins; and the EGF Mapping System using electrographic flow mapping to detect and quantify patterns of electrical wavefront propagation in the atria.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ablacon company profile →
Semprus Biosciences
HQ: United States
Website
- Description: Provider of medical devices implementing the multi-faceted Semprus technology, currently focused on developing a vascular access catheter incorporating a single surface modification. Headquartered in Cambridge, Massachusetts.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Semprus Biosciences company profile →
FlowCardia
HQ: United States
Website
- Description: Provider of catheter-based medical device technologies that facilitate guidewire crossing and treatment of totally occluded coronary and peripheral arteries (Chronic Total Occlusions).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full FlowCardia company profile →
Sorin
HQ: Italy
Website
- Description: Provider of medical technologies for cardiac surgery and the treatment of cardiac rhythm disorders. A global medical device company that develops, manufactures, and markets solutions for cardiovascular disease care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sorin company profile →
Conor Medsystems
HQ: United States
Website
- Description: Provider of innovative controlled vascular drug delivery technologies, initially focused on developing drug-eluting stents to treat coronary artery disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Conor Medsystems company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Intelesens
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Intelesens
2.2 - Growth funds investing in similar companies to Intelesens
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Intelesens
4.2 - Public trading comparable groups for Intelesens
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →